Canada · Health Canada Drug Product Database

SUBOXONE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 95646
DIN: 02468085
Form: Tablet
Company as listed by source: INDIVIOR UK LIMITED
Source status: Marketed (2018-02-14)
Source last updated: 2025-03-22

Source-listed ingredients

BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) — 12 MG
NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE) — 3 MG

These values do not establish equivalence or a dose recommendation.

Packages

7/28

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →